Patent: 7,833,527

Summary for Patent: 7,833,527

Title:	Methods of treating psoriasis using IL-17 Receptor A antibodies
Abstract:	The present invention relates to IL-17 Receptor A antigen binding proteins, such as antibodies, and methods for diagnosing and treating diseases mediated by IL-17 Receptor A activation.
Inventor(s):	Joel Tocker, Jacques J. Peschon, David Fitzpatrick
Assignee:	Amgen K A Inc
Application Number:	US11/906,078
Patent Claims:	see list of patent claims

United States Patent 7,833,527: What Do the Claims Cover and How Strong Is the US Patent Estate?

No usable claim text was provided. Without the actual claim language (independent and dependent claims), a complete, accurate claim-by-claim analysis and a litigation-grade patent-landscape mapping cannot be produced.

Key Takeaways

• United States Patent 7,833,527 requires full claim text to assess scope, validity risk, and design-around pathways.
• A critical landscape analysis also requires the patent’s bibliographic record (assignee, filing/priority dates, exam history, continuations) and the related forward-citation and family members to connect claim scope to current competitors.

FAQs

1. What is the fastest way to assess whether US 7,833,527 is vulnerable to invalidity?
2. How do dependent claims in US 7,833,527 typically narrow claim scope in litigation?
3. Which common design-arounds most often bypass narrow formulation or method-of-use claims?
4. How do forward citations and continuation filings affect the practical strength of US 7,833,527?
5. What Orange Book or FDA exclusivity linkage would matter most for US 7,833,527’s enforcement value?

References

1. (No sources cited because the necessary patent claim text and bibliographic record were not provided.)

Details for Patent 7,833,527

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Valeant Pharmaceuticals Luxembourg S.à.r.l.	SILIQ	brodalumab	Injection	761032	February 15, 2017	7,833,527	2027-09-27

International Patent Family for US Patent 7,833,527

Country	Patent Number	Estimated Expiration
South Africa	200902018
World Intellectual Property Organization (WIPO)	2008054603
United States of America	10208122
United States of America	11180564
United States of America	11858999
United States of America	2008219979